StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.26+0.04 (+1.80%)

Close on Nov 18, 2026Market cap $441.37MP/E –Yield –

Ovid Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ovid Therapeutics's market cap was $513.62M on Nov 11, 2026, against $126.65M a year earlier. Over the last 5 years it ranged from $19.36M to $513.62M, with a median of $181.80M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$513.62M+342.9%
2025Dec 31, 2025$115.98M+74.9%
2024Dec 31, 2024$66.30M-70.9%
2023Dec 29, 2023$227.59M+73.6%
2022Dec 30, 2022$131.07M-40.0%
2021Dec 31, 2021$218.33M+49.0%
2020Dec 31, 2020$146.54M-5.8%
2019Dec 31, 2019$155.49M+160.6%
2018Dec 31, 2018$59.66M-75.4%
2017Dec 29, 2017$242.82M–

More Ovid Therapeutics figures

See a number that looks wrong?